(Q48704763)

14 February 2018

title

Low-flow oxygen and bilevel ventilatory support: effects on ventilation during sleep in cystic fibrosis. (English)

1 reference

14 February 2018

0 references

Milross MA

1

1 reference

14 February 2018

Piper AJ

2

1 reference

14 February 2018

Norman M

3

1 reference

14 February 2018

Becker HF

4

1 reference

14 February 2018

Willson GN

5

1 reference

14 February 2018

Grunstein RR

6

1 reference

14 February 2018

Sullivan CE

7

1 reference

14 February 2018

Bye PT

8

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 January 2001

1 reference

14 February 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

14 February 2018

volume

163

1 reference

14 February 2018

issue

1

1 reference

14 February 2018

page(s)

129-134

1 reference

14 February 2018

Mechanism of hemoglobin desaturation during rapid-eye-movement sleep in normal subjects and in patients with cystic fibrosis.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2005130

Ventilation and oxygenation changes during sleep in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2005130

Cystic fibrosis in adults. 75 cases and a review of 232 cases in the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2005130

Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2005130

Use of bilevel positive airway pressure (BIPAP) in end-stage patients with cystic fibrosis awaiting lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2005130

Nocturnal nasal IPPV stabilizes patients with cystic fibrosis and hypercapnic respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2005130

Long-term nasal intermittent positive pressure ventilation in patients with cystic fibrosis and hypercapnic respiratory failure (1991-1996).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2005130

Use of BiPAP by nasal mask in the treatment of respiratory insufficiency in pediatric patients: preliminary investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2005130

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2005130

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2005130

Predicted normal values for maximal respiratory pressures in caucasian adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2005130

Breathing during sleep in patients with nocturnal desaturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2005130

A comparison of different modes of noninvasive ventilatory support: effects on ventilation and inspiratory muscle effort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2005130

Nasal continuous positive airway pressure facilitates respiratory muscle function during sleep in severe chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2005130

Benefits of nocturnal nasal CPAP in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2005130

Effects of non-REM sleep on ventilation and respiratory mechanics in adults with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.163.1.2005130

10.1164/AJRCCM.163.1.2005130

21 January 2018

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018